Commentary · 26 Dec 2022
Conference abstractPublished 15 Jul 2022
Coronary Artery disease
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Coronary heart disease which is also known as the coronary artery disease is caused when the coronary arteries become too narrow. Coronary heart disease is developed when the cholesterol builds up on the walls of the artery and creates plaque. These plaques cause the arteries to narrow and reduce the blood flow to the heart. Coronary heart disease can sometimes lead to heart attack. CHD develops as a result of the injury or damage to the inner layer of a coronary artery. CHD can leads to other conditions like angina. CHD can also leads to the shortness of breath. Heart attack may also occurs when the heart muscles does not get enough blood or oxygen, due to the blood clots formation from plaque in any of the coronary arteries. This formation of blood clot is called coronary thrombosis. This clot is big enough and can stop the supply of the blood to the heart. Some of the symptoms of the heart attack are chest discomfort, mild or crushing chest pain, and dizziness, shortness of breath, restlessness, nausea and vomiting, sweating and general discomfort. The first symptom is usually the chest pain that spreads to the neck, jaw, ears, arms and the wrists and to the shoulder blades, back or the abdomen. A heart attack is the medical emergency which may result in death or the permanent heart damage. There is no cure for the CHD. Treatment may be done by making the healthful lifestyles changes like adopting a healthful diet, quitting smoking and by doing regular exercise. Medications that are used to reduce the risk or the impact of the CHD may include beta-blockers, nitroglycerin patches, sprays or tablets, angiotensin-converting enzymes inhibitors, calcium channels blockers and statins. Surgical procedures can also open or replace the blocked arteries if they have become very narrow, or if the symptoms are not responding to the medications like laser surgery, coronary bypass surgery, and angioplasty and stent placement. CHD can be prevented by controlling the blood cholesterol levels. Some factors that increase the person’s risk of developing CHD are having high blood pressure, having high levels of low-density lipoproteins or having low levels of high-densitylipoproteins, smoking and being obese. CHD can be diagnosed by electrocardiogram, holter monitor and echocardiogram. According to World Health Organization (WHO) data, in 2008, the mortality rate due to coronary heart diseases was 214-455 deaths per 100,000.
Keywords
Subjects
Pharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Perspective · 8 Sep 2022
Cardiac Catheterization in Patients with Coronary Artery Disease
Short communication · 25 Jul 2022
Effects of direct renin inhibition on atherosclerotic biomarkers in patients with stable coronary artery disease and type 2 diabetes mellitus
Perspective · 6 Jun 2022
Association between Hypertension and Coronary Artery Disease
Opinion · 6 May 2022
Interim Trends in Cardiac Stress Tests in Patients with Suspected Coronary Artery Disease
More from this journal
The newest in Journal of In Silico & In Vitro Pharmacology.
Short communication · 31 Mar 2025
Predictive Pharmacology in Action: Combining Molecular modelling and Laboratory Validation for Efficient Drug Development
Perspective · 31 Mar 2025
From Virtual Screening to Biological Validation: Integrating In Silico and In Vitro Strategies for Predictive Pharmacology
Opinion · 31 Mar 2025
Computational and Experimental Synergy: A Dual Approach to Pharmacological Profiling
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of In Silico & In Vitro Pharmacology
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Zeeshan Habib”

